{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:34:55Z","timestamp":1761975295462},"reference-count":32,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1339,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1111\/j.1529-8019.2012.01494.x","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T14:37:26Z","timestamp":1337179046000},"page":"12-22","source":"Crossref","is-referenced-by-count":19,"title":["Cutaneous and systemic adverse reactions to antibiotics"],"prefix":"10.1155","volume":"25","author":[{"given":"LUCIA","family":"DIAZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANA M.","family":"CIUREA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB1|cit1","first-page":"88","volume-title":"Contact dermatitis and drug eruptions. Andrews' diseases of the skin","author":"James","year":"2011"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB2|cit2","volume-title":"Pocketbook of drug eruptions and interactions","author":"Litt","year":"2009"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/B978-1-4377-0412-9.00020-4","volume-title":"The hypersensitivity syndromes. Hurwitz clinical pediatric dermatology","author":"Paller","year":"2011"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB4|cit4","volume-title":"Practical dermatopathology","author":"Rapini","year":"2005"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/infdis\/128.Supplement_2.S364","article-title":"Antigenicity and cross reactivitiy of penicillins and cephalosporins","volume":"128","author":"Levine","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB6|cit6","first-page":"1153","article-title":"Cross reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins","volume":"59","author":"Romano","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.mcna.2009.08.004","article-title":"Allergic skin disease: major highlights and recent advances","volume":"93","author":"Nichols","year":"2009","journal-title":"Med Clin North Am"},{"issue":"10","key":"10.1111\/j.1529-8019.2012.01494.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archpedi.1997.02170470048009","article-title":"Herpes simplex virus-associated erythema multiforme in prepubertal children","volume":"151","author":"Weston","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000018378","article-title":"Dapsone responsive persistent erythema multiforme","volume":"3","author":"Mahendran","year":"2000","journal-title":"Dermatology"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01494.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00128071-200809020-00006","article-title":"Persistent erythema multiforme treated with thalidomide","volume":"9","author":"Chen","year":"2008","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01494.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1440-0960.2004.00130.x","article-title":"Intermittent oral cyclosporine for recurrent herpes simplex-associated erythema multiforme","volume":"46","author":"Bakis","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB12|cit12","first-page":"978","volume-title":"Comprehensive dermatologic therapy","author":"Knowles","year":"2007"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-3476(06)80187-3","article-title":"Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility","volume":"125","author":"Kearns","year":"1994","journal-title":"J Pediatr"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jama.1996.03540120028017","article-title":"Cefaclor and serum sickness-like reaction","volume":"276","author":"Reynolds","year":"1996","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(00)03137-8","article-title":"Idiosyncratic drug reactions: the reactive metabolite syndromes","volume":"356","author":"Knowles","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archderm.1996.03890320082013","article-title":"Serious adverse reactions induced by minocycline: a report of 13 patients and review of the literature","volume":"132","author":"Knowles","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clindermatol.2003.12.023","article-title":"Drug-induced lupus erythematosus","volume":"22","author":"Antonov","year":"2004","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01494.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0733-8635(05)70309-0","article-title":"New advances in severe adverse drug reactions","volume":"19","author":"Revuz","year":"2001","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/09546630802683843","article-title":"The molecular mechanisms of etanercept, an anti-tumor necrosis factor alpha receptor fusion protein, in the treatment of acute generalized exanthematous pustulosis","volume":"20","author":"Gencoglan","year":"2009","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1111\/j.1529-8019.2012.01494.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1468-3083.2006.02026.x","article-title":"Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumor necrosis factor alpha antibody infliximab: report of three cases","volume":"21","author":"Meiss","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1111\/j.1529-8019.2012.01494.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1111\/j.1365-2230.2009.03480.x","article-title":"Rapid clearing of acute generalized exanthematous pustulosis after administration of cyclosporine","volume":"34","author":"Di Lernia","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1111\/j.1529-8019.2012.01494.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/00128071-200304080-00006","article-title":"Differential diagnosis of severe cutaneous drug eruptions","volume":"4","author":"Bachot","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clindermatol.2004.06.012","article-title":"Life threatening acute adverse cutaneous drug reactions","volume":"23","author":"Wolf","year":"2005","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01494.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","article-title":"Treatment of toxic epidermal necrolysis with cyclosporine A","volume":"48","author":"Arevalo","year":"2000","journal-title":"J Trauma"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-4362.1997.00192.x","article-title":"Plasmapheresis in toxic epidermal necrolysis","volume":"36","author":"Haidemenos","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","article-title":"Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases","volume":"139","author":"Prins","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/0378-6323.18943","article-title":"Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: an open uncontrolled study","volume":"71","author":"Mangla","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB28|cit28","first-page":"119","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: 11 years experience and outcome","volume":"11","author":"Gravante","year":"2007","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.mcna.2010.04.004","article-title":"Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"94","author":"Harr","year":"2010","journal-title":"Med Clin North Am"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01494.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0190-9622(03)02111-X","article-title":"Treatment of severe lichen planus with mycophenolate mofetil","volume":"49","author":"Frieling","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01494.x-BIB31|cit31","first-page":"37","article-title":"Treatment of sever cutaneous ulcerative lichen planus with low molecular weight heparin in a patient with hepatitis C","volume":"79","author":"Neville","year":"2007","journal-title":"Cutis"},{"key":"10.1111\/j.1529-8019.2012.01494.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0190-9622(83)70110-6","article-title":"Potassium iodide in erythema nodosum and other erythematous dermatoses","volume":"9","author":"Horio","year":"1983","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2012.01494.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2012.01494.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T16:33:21Z","timestamp":1713976401000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2012.01494.x"}},"subtitle":["Cutaneous and systemic adverse reactions"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01494.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}